K
Kenneth Egstrup
Researcher at Odense University Hospital
Publications - 185
Citations - 9062
Kenneth Egstrup is an academic researcher from Odense University Hospital. The author has contributed to research in topics: Myocardial infarction & Heart failure. The author has an hindex of 40, co-authored 172 publications receiving 8144 citations. Previous affiliations of Kenneth Egstrup include Aarhus University Hospital & Umeå University.
Papers
More filters
Journal ArticleDOI
Intensive lipid lowering with simvastatin and ezetimibe in aortic stenosis.
Anne B. Rossebø,Terje R. Pedersen,Kurt Boman,Philippe Brudi,John C. Chambers,Kenneth Egstrup,Eva Gerdts,Christa Gohlke-Bärwolf,Ingar Holme,Y. Antero Kesäniemi,William Malbecq,Christoph A. Nienaber,Simon Ray,Terje Skjærpe,Kristian Wachtell,Ronnie Willenheimer +15 more
TL;DR: Simvastatin and ezetimibe did not reduce the composite outcome of combined aortic-valve events and ischemic events in patients with aorti stenosis, and such therapy reduced the incidence of isChemic cardiovascular events but not events related to aorting stenosis.
Journal ArticleDOI
Defibrillator Implantation in Patients with Nonischemic Systolic Heart Failure
Lars Køber,Jens Jakob Thune,Jens Jakob Thune,Jens Nielsen,Jens Nielsen,Jens Haarbo,Jens Haarbo,Lars Videbæk,Eva Korup,Jensen G,Per Hildebrandt,Flemming Hald Steffensen,Niels Eske Bruun,Niels Eske Bruun,Niels Eske Bruun,Hans Eiskjær,Hans Eiskjær,Axel Brandes,Anna Margrethe Thøgersen,Finn Gustafsson,Kenneth Egstrup,Regitze Videbæk,Christian Hassager,Jesper Hastrup Svendsen,Dan Eik Høfsten,Christian Torp-Pedersen,S. Pehrson +26 more
TL;DR: In this trial, prophylactic ICD implantation in patients with symptomatic systolic heart failure not caused by coronary artery disease was not associated with a significantly lower long-term rate of death from any cause than was usual clinical care.
Journal ArticleDOI
Dofetilide in patients with congestive heart failure and left ventricular dysfunction. Danish Investigations of Arrhythmia and Mortality on Dofetilide Study Group.
Torp-Pedersen Ct,Mogens Møller,P E Bloch-Thomsen,Lars Køber,Erik Sandoe,Kenneth Egstrup,Agner E,Carlsen Je,Jørgen Videbæk,Bradley Marchant,A. J. Camm +10 more
TL;DR: In patients with congestive heart failure and reduced left ventricular function, dofetilide was effective in converting atrial fibrillation, preventing its recurrence, and reducing the risk of hospitalization for worsening heart failure.
Journal ArticleDOI
Effect of dofetilide in patients with recent myocardial infarction and left-ventricular dysfunction: a randomised trial.
Lars Køber,Poul Erik Bloch Thomsen,Mogens Møller,Christian Torp-Pedersen,Carlsen Je,Erik Sandoe,Kenneth Egstrup,Agner E,Jørgen Videbæk,Bradley Marchant,A. John Camm +10 more
TL;DR: In patients with severe left-ventricular dysfunction and recent myocardial infarction, treatment with dofetilide did not affect all-cause mortality, cardiac mortality, or total arrhythmic deaths, and dofetilide was effective in treating atrial fibrillation or flutter in this population.
Journal ArticleDOI
Outcome of Patients With Low-Gradient “Severe” Aortic Stenosis and Preserved Ejection Fraction
Nikolaus Jander,Jan Minners,Ingar Holme,Eva Gerdts,Kurt Boman,Philippe Brudi,John C. Chambers,Kenneth Egstrup,Y. Antero Kesäniemi,William Malbecq,Christoph A. Nienaber,Simon Ray,Anne B. Rossebø,Terje R. Pedersen,Terje Skjærpe,Ronnie Willenheimer,Kristian Wachtell,Franz-Josef Neumann,Christa Gohlke-Bärwolf +18 more
TL;DR: Patients with low-gradient “severe” aortic stenosis and normal ejection fraction have an outcome similar to that in patients with moderate stenosis.